TAUB REBECCA sold 9.2% of their position (46.46K shares) of MADRIGAL PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $16.51M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+3.20K
Price / share
$9.45
Trade value
$30.24K
% of position
Common Stock
Shares
−2.98K
Price / share
$350.18
Trade value
$1.04M
% of position
Common Stock
Shares
−220.00
Price / share
$351.02
Trade value
$77.22K
% of position
Common Stock
Shares
+43.26K
Price / share
$9.45
Trade value
$408.84K
% of position
Common Stock
Shares
−3.58K
Price / share
$350.87
Trade value
$1.26M
% of position
Common Stock
Shares
−2.87K
Price / share
$351.60
Trade value
$1.01M
% of position
Common Stock
Shares
−1.18K
Price / share
$352.45
Trade value
$414.13K
% of position
Common Stock
Shares
−4.59K
Price / share
$354.04
Trade value
$1.62M
% of position
Common Stock
Shares
−6.48K
Price / share
$354.97
Trade value
$2.30M
% of position
Common Stock
Shares
−5.75K
Price / share
$355.95
Trade value
$2.05M
% of position
Common Stock
Shares
−4.86K
Price / share
$356.88
Trade value
$1.74M
% of position
Common Stock
Shares
−6.71K
Price / share
$357.85
Trade value
$2.40M
% of position
Common Stock
Shares
−6.54K
Price / share
$358.81
Trade value
$2.35M
% of position
Common Stock
Shares
−700.00
Price / share
$359.71
Trade value
$251.80K
% of position
Net shares
+0.00
Net value
-$16.07M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/11/2025 | M · Option Exercise | +3.20K | $9.45 | $30.24K | 0.7% | 461.04K | 464.24K |
| Common Stock Direct | 8/11/2025 | S · Sale | −2.98K | $350.18 | $1.04M | 0.6% | 464.24K | 461.26K |
| Common Stock Direct | 8/11/2025 | S · Sale | −220.00 | $351.02 | $77.22K | 0.0% | 461.26K | 461.04K |
| Common Stock Direct | 8/12/2025 | M · Option Exercise | +43.26K | $9.45 | $408.84K | 9.4% | 461.04K | 504.31K |
| Common Stock Direct | 8/12/2025 | S · Sale | −3.58K | $350.87 | $1.26M | 0.7% | 504.31K | 500.73K |
| Common Stock Direct | 8/12/2025 | S · Sale | −2.87K | $351.60 | $1.01M | 0.6% | 500.73K | 497.86K |
| Common Stock Direct | 8/12/2025 | S · Sale | −1.18K | $352.45 | $414.13K | 0.2% | 497.86K | 496.68K |
| Common Stock Direct | 8/12/2025 | S · Sale | −4.59K | $354.04 | $1.62M | 0.9% | 496.68K | 492.10K |
| Common Stock Direct | 8/12/2025 | S · Sale | −6.48K | $354.97 | $2.30M | 1.3% | 492.10K | 485.62K |
| Common Stock Direct | 8/12/2025 | S · Sale | −5.75K | $355.95 | $2.05M | 1.2% | 485.62K | 479.86K |
| Common Stock Direct | 8/12/2025 | S · Sale | −4.86K | $356.88 | $1.74M | 1.0% | 479.86K | 475K |
| Common Stock Direct | 8/12/2025 | S · Sale | −6.71K | $357.85 | $2.40M | 1.4% | 475K | 468.29K |
| Common Stock Direct | 8/12/2025 | S · Sale | −6.54K | $358.81 | $2.35M | 1.4% | 468.29K | 461.74K |
| Common Stock Direct | 8/12/2025 | S · Sale | −700.00 | $359.71 | $251.80K | 0.2% | 461.74K | 461.04K |
| Total | +0.00 | -$16.07M | ||||||
Stock Option (Right to Buy)
Common Stock
3.20K shares
Shares
−3.20K
Strike price
9.45
Held after
43.26K
Exercisable
—
Stock Option (Right to Buy)
Common Stock
43.26K shares
Shares
−43.26K
Strike price
9.45
Held after
0.00
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock3.20K shares | 8/11/2025 | M · Option Exercise | −3.20K | 9.45 | — | 43.26K |
| Stock Option (Right to Buy) Direct | Common Stock43.26K shares | 8/12/2025 | M · Option Exercise | −43.26K | 9.45 | — | 0.00 |
Common Stock
Indirect| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 655.54K | Indirect |
| Total | 655.54K | 655.54K indirect |